Turkish Journal of Gastroenterology最新文献

筛选
英文 中文
A Rare Case of Early Gastric Mixed Neuroendocrine-Non-Neuroendocrine Neoplasm. 早期胃神经内分泌-非神经内分泌混合性肿瘤1例。
IF 1.4 4区 医学
Turkish Journal of Gastroenterology Pub Date : 2025-03-25 DOI: 10.5152/tjg.2025.24574
Shouxin Yin, Shuai Han, Shuangshuang Ren
{"title":"A Rare Case of Early Gastric Mixed Neuroendocrine-Non-Neuroendocrine Neoplasm.","authors":"Shouxin Yin, Shuai Han, Shuangshuang Ren","doi":"10.5152/tjg.2025.24574","DOIUrl":"https://doi.org/10.5152/tjg.2025.24574","url":null,"abstract":"","PeriodicalId":51205,"journal":{"name":"Turkish Journal of Gastroenterology","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2025-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144004445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Applicability of ESPGHAN Biopsy-Free Guidelines for Celiac Disease Diagnosis: Insights from Türkiye. ESPGHAN无活检指南在乳糜泻诊断中的适用性:来自<s:1> rkiye的见解。
IF 1.4 4区 医学
Turkish Journal of Gastroenterology Pub Date : 2025-03-19 DOI: 10.5152/tjg.2025.24718
Zeren Barış, Müberra Canbaz, Beyzanur Yılmaz, Neslihan Üstün, Yusuf Aydemir
{"title":"Applicability of ESPGHAN Biopsy-Free Guidelines for Celiac Disease Diagnosis: Insights from Türkiye.","authors":"Zeren Barış, Müberra Canbaz, Beyzanur Yılmaz, Neslihan Üstün, Yusuf Aydemir","doi":"10.5152/tjg.2025.24718","DOIUrl":"https://doi.org/10.5152/tjg.2025.24718","url":null,"abstract":"<p><strong>Background/aims: </strong>The biopsy-free diagnostic approach for celiac disease (CD) in children, recommended by ESPGHAN guidelines, is not widely implemented in pediatric gastroenterology centers across Türkiye. This study aimed to retrospectively evaluate patients who met ESPGHAN biopsy-free criteria but were nonetheless diagnosed through biopsy.</p><p><strong>Materials and methods: </strong>Of 180 pediatric patients diagnosed with CD in the authors' department over 5 years, 79 (43.8%) met the ESPGHAN biopsy-free criteria. All patients underwent routine biopsies of the duodenum, bulb, antrum, corpus, and esophagus at diagnosis. Clinical presentations, celiac serology, and endoscopic and histopathological findings were retrospectively analyzed.</p><p><strong>Results: </strong>The mean age at diagnosis was 7.48 ± 4 years (range, 2-17; M/F: 38/41). Presenting symptoms included growth failure (32.9%), abdominal pain (22.8%), constipation (8.9%), diarrhea (7.6%), anemia (6.3%), vomiting (5%), and elevated liver enzymes (1.3%). Fourteen patients (17.7%) were diagnosed via screening; 9 (64.3%) had type 1 diabetes. Endoscopy findings were consistent with CD in 77 patients; 2 had normal results. Non-celiac endoscopic findings were seen in 19 patients. Histopathology confirmed Marsh 3 lesions in 78 patients; 1 had normal findings, with tTG IgA levels normalizing at a 4-month follow-up. The positive predictive value of biopsy-free criteria was 98.7%. Non-celiac findings (in 24 patients) included Helicobacter pylori gastritis (n = 7) and eosinophilic esophagitis (n = 2).</p><p><strong>Conclusion: </strong>The biopsy-free diagnostic approach accurately identifies CD in most cases but may miss treatable conditions like eosinophilic esophagitis or H. pylori infection, especially in endemic regions. Misdiagnoses, though rare, highlight the need for careful evaluation in populations with diverse clinical presentations.</p>","PeriodicalId":51205,"journal":{"name":"Turkish Journal of Gastroenterology","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144038908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retrospective Studies with Small Sample Size are Still Dominating Colon Cancer Research: Local Recurrence in Right Sided Colon Cancer as a Case in Point. 小样本量的回顾性研究仍是结肠癌研究的主流:以右侧结肠癌局部复发为例。
IF 1.4 4区 医学
Turkish Journal of Gastroenterology Pub Date : 2025-03-19 DOI: 10.5152/tjg.2025.24749
Yusra Khan, Zhi Sean Teng, Raza Sayyed, Alaa El-Hussuna
{"title":"Retrospective Studies with Small Sample Size are Still Dominating Colon Cancer Research: Local Recurrence in Right Sided Colon Cancer as a Case in Point.","authors":"Yusra Khan, Zhi Sean Teng, Raza Sayyed, Alaa El-Hussuna","doi":"10.5152/tjg.2025.24749","DOIUrl":"10.5152/tjg.2025.24749","url":null,"abstract":"","PeriodicalId":51205,"journal":{"name":"Turkish Journal of Gastroenterology","volume":"36 5","pages":"333-335"},"PeriodicalIF":1.4,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12070443/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144052348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
White Bile Detected During Endoscopic Retrograde Cholangiopancreatography: A Rare Phenomenon and Its Clinical Implications. 内窥镜逆行胆管造影中发现白胆汁:一种罕见现象及其临床意义。
IF 1.4 4区 医学
Turkish Journal of Gastroenterology Pub Date : 2025-03-19 DOI: 10.5152/tjg.2025.25018
İdris Kurt, Yalçın Taymez, Görkem Karadağ
{"title":"White Bile Detected During Endoscopic Retrograde Cholangiopancreatography: A Rare Phenomenon and Its Clinical Implications.","authors":"İdris Kurt, Yalçın Taymez, Görkem Karadağ","doi":"10.5152/tjg.2025.25018","DOIUrl":"https://doi.org/10.5152/tjg.2025.25018","url":null,"abstract":"","PeriodicalId":51205,"journal":{"name":"Turkish Journal of Gastroenterology","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143997482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lower Serum HBV RNA Level is Associated with Liver Cirrhosis in Patients Treated with Nucleos(t)ide Analogs: A Population-Based Cross-Sectional Study. 低血清HBV RNA水平与核苷类似物治疗患者肝硬化相关:一项基于人群的横断面研究
IF 1.4 4区 医学
Turkish Journal of Gastroenterology Pub Date : 2025-03-18 DOI: 10.5152/tjg.2025.24648
Juanli Wu, Yushuang Zhang, Han Gao, Yiheng Zhang, Tao Li, Lei Wang, Yundong Qu
{"title":"Lower Serum HBV RNA Level is Associated with Liver Cirrhosis in Patients Treated with Nucleos(t)ide Analogs: A Population-Based Cross-Sectional Study.","authors":"Juanli Wu, Yushuang Zhang, Han Gao, Yiheng Zhang, Tao Li, Lei Wang, Yundong Qu","doi":"10.5152/tjg.2025.24648","DOIUrl":"https://doi.org/10.5152/tjg.2025.24648","url":null,"abstract":"<p><strong>Background/aims: </strong>There is evidence suggesting an association between hepatitis B virus (HBV) RNA and hepatic fibrosis in treatmentnaïve chronic hepatitis B (CHB) patients. However, few studies have delved into the relevance between HBV RNA and HBV-related cirrhosis. The purpose of this article is to elucidate the connection between HBV RNA and cirrhosis in patients undergoing nucleos(t)ide analogs (NAs).</p><p><strong>Materials and methods: </strong>This study included 381 patients. Logistic regression was employed to investigate the variables linked to the development of cirrhosis. Propensity score matching was used to correct for confounders.</p><p><strong>Results: </strong>In this cross-sectional study, multivariable logistic regression showed HBV RNA detectability was associated with cirrhosis. Multivariate regression suggests that the variables associated with cirrhosis were: older age, HBV RNA above the lower limit of quantification, shorter duration of treatment, higher level of serum bilirubin, and treatment strategy. Among patients with quantifiable HBV RNA (n = 242), cirrhotic patients exhibit lower median serum HBV RNA titers compared to those with CHB patients. Furthermore, qHBsAg ≤ 3.3 lg IU/mL and qHBV RNA ≤ 3.7 lg copies/mL may be linked to cirrhosis.</p><p><strong>Conclusion: </strong>Nucleos(t)ide analogs treatment may result in varying degrees of decrease in HBV RNA levels. Lower levels of HBV RNA may be linked to the development of cirrhosis.</p>","PeriodicalId":51205,"journal":{"name":"Turkish Journal of Gastroenterology","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2025-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144031387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Low Circulating Levels of Omentin-1 and Irisin in Type 2 Diabetes Mellitus Patients with Metabolic-Associated Fatty Liver Disease. 2型糖尿病合并代谢性脂肪肝患者低循环水平的网膜蛋白-1和鸢尾素
IF 1.4 4区 医学
Turkish Journal of Gastroenterology Pub Date : 2025-03-17 DOI: 10.5152/tjg.2025.24639
Hua-Ying Li, Yan-Yan Zhang, Xia-Ming Cai, Xiang Chen
{"title":"Low Circulating Levels of Omentin-1 and Irisin in Type 2 Diabetes Mellitus Patients with Metabolic-Associated Fatty Liver Disease.","authors":"Hua-Ying Li, Yan-Yan Zhang, Xia-Ming Cai, Xiang Chen","doi":"10.5152/tjg.2025.24639","DOIUrl":"https://doi.org/10.5152/tjg.2025.24639","url":null,"abstract":"<p><strong>Background/aims: </strong>The study analyzed the roles of circulating omentin-1 and irisin in patients with type 2 diabetes mellitus (T2DM) concomitant with metabolic-associated fatty liver disease (MAFLD).</p><p><strong>Materials and methods: </strong>This cross-sectional study included 80 patients with T2DM but no MAFLD, 62 patients with MAFLD but no T2DM, 50 T2DM patients having MAFLD (T2DM/MAFLD), and 80 healthy individuals.</p><p><strong>Results: </strong>The serum levels of omentin-1 and irisin were both significantly reduced in patients with T2DM coexisting with MAFLD compared to T2DM or MAFLD patients alone. In T2DM patients, the level of omentin-1 decreased as the level of fasting plasma glucose (FPG) increased and the level of high-density lipoprotein cholesterol (HDL-C) reduced; the level of irisin decreased as the levels of FPG and fasting insulin (FINS) increased. In MAFLD patients, a lower level of omentin-1 was correlated with a lower level of HDL-C but with a greater waist-to-hip ratio (WHR), alanine aminotransferase and aspartate aminotransferase levels; a lower level of irisin was correlated with higher WHR and FINS level. In patients with T2DM coexisting with MAFLD, those with a lower level of omentin-1 were found to have a lower level of HDL-C concurrent with lower WHR and triglyceride level; and those with a lower level of irisin showed lower WHR, FPG and FINS levels. Combined evaluation of omentin-1 and irisin for diagnosing T2DM coexisting with MAFLD yielded an area under the curve of 0.943.</p><p><strong>Conclusion: </strong>These findings suggest the assessment potential of omentin-1 and irisin for T2DM coexisting with MAFLD.</p>","PeriodicalId":51205,"journal":{"name":"Turkish Journal of Gastroenterology","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144027478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Liver Transplantation for Autoimmune Hepatitis: Infections are the Major Cause of Mortality. 自身免疫性肝炎的肝移植:感染是死亡的主要原因。
IF 1.4 4区 医学
Turkish Journal of Gastroenterology Pub Date : 2025-03-03 DOI: 10.5152/tjg.2025.0201252
Nilay Danış, Fulya Günşar
{"title":"Liver Transplantation for Autoimmune Hepatitis: Infections are the Major Cause of Mortality.","authors":"Nilay Danış, Fulya Günşar","doi":"10.5152/tjg.2025.0201252","DOIUrl":"10.5152/tjg.2025.0201252","url":null,"abstract":"","PeriodicalId":51205,"journal":{"name":"Turkish Journal of Gastroenterology","volume":"36 3","pages":"133-134"},"PeriodicalIF":1.4,"publicationDate":"2025-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11899962/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143651685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum. 勘误表。
IF 1.4 4区 医学
Turkish Journal of Gastroenterology Pub Date : 2025-02-28 DOI: 10.5152/tjg.2025.030626
{"title":"Erratum.","authors":"","doi":"10.5152/tjg.2025.030626","DOIUrl":"https://doi.org/10.5152/tjg.2025.030626","url":null,"abstract":"","PeriodicalId":51205,"journal":{"name":"Turkish Journal of Gastroenterology","volume":"36 4","pages":"265"},"PeriodicalIF":1.4,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144040372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Associations of Metabolically Healthy Obesity with Gastroesophageal Reflux Disease and Ineffective Esophageal Motility. 代谢健康肥胖与胃食管反流病和食道运动不良的关系
IF 1.4 4区 医学
Turkish Journal of Gastroenterology Pub Date : 2025-02-11 DOI: 10.5152/tjg.2025.24351
Tao He, Li-Ping Su, Shun-Zhe Song, Yu-Fei Li, Li-Xia Wang, Shan-Ming Sun
{"title":"Associations of Metabolically Healthy Obesity with Gastroesophageal Reflux Disease and Ineffective Esophageal Motility.","authors":"Tao He, Li-Ping Su, Shun-Zhe Song, Yu-Fei Li, Li-Xia Wang, Shan-Ming Sun","doi":"10.5152/tjg.2025.24351","DOIUrl":"https://doi.org/10.5152/tjg.2025.24351","url":null,"abstract":"<p><strong>Background/aims: </strong>Obesity correlates with a higher prevalence of gastroesophageal reflux disease (GERD) and ineffective esophageal motility (IEM); however, the connection between metabolic obesity phenotype and these symptoms is poorly explored. Here, empirical data were used to explore the relationships between phenotypes of metabolic obesity and GERD and IEM.</p><p><strong>Materials and methods: </strong>The present retrospective study involved 605 patients demonstrating typical reflux symptoms, categorized into 4 phenotypes: metabolically healthy obesity (MHO), metabolically healthy non-obesity (MHNO), metabolically unhealthy obesity (MUO), and metabolically unhealthy non-obesity (MUNO). The study excluded cases who were underweight, with severe comorbidities, prior gastric surgeries, or an absence of complete data. A 24-hour multichannel intraluminal impedance-pH system was used for monitoring.</p><p><strong>Results: </strong>Patients exhibiting MUO, MHO, and MUNO phenotypes demonstrated a higher risk of GERD (pathological acid exposure time (AET), >6%) and IEM compared to those with the MHNO phenotype. Potential confounders, such as sex, age, body mass index, waist-hipratio, smoking status, alcohol intake, psychosocial stress, socioeconomic status, dietary practices, and opioid usage were adjusted, with the results indicating that the MUO phenotype was linked to the highest risk of pathological AET [15.78 (95% CI: 4.72-52.73)]; IEM [3.00 (95% CI: 1.31-6.87)].</p><p><strong>Conclusion: </strong>The effects of obesity on GERD and IEM incidence could exceed those of metabolic diseases.</p>","PeriodicalId":51205,"journal":{"name":"Turkish Journal of Gastroenterology","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2025-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144040405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IREB2 Knockdown Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease by TLR4/NF-κB Signaling Inactivation. IREB2敲低通过TLR4/NF-κB信号失活缓解高脂饮食诱导的非酒精性脂肪肝
IF 1.4 4区 医学
Turkish Journal of Gastroenterology Pub Date : 2025-02-04 DOI: 10.5152/tjg.2025.24054
Yongmin Hu, Shengjun Zhang, Qingjian Jiang, Tengqian Chen, Jia Luo, Yigui Jiang
{"title":"IREB2 Knockdown Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease by TLR4/NF-κB Signaling Inactivation.","authors":"Yongmin Hu, Shengjun Zhang, Qingjian Jiang, Tengqian Chen, Jia Luo, Yigui Jiang","doi":"10.5152/tjg.2025.24054","DOIUrl":"https://doi.org/10.5152/tjg.2025.24054","url":null,"abstract":"<p><strong>Background/aims: </strong>Nonalcoholic fatty liver disease (NAFLD) is one of the most prevalent chronic liver diseases and is characterized by extensive deposition of fat in hepatocytes. This study aims to elucidate iron responsive element binding protein 2's (IREB2) role in highfat diet (HFD)-induced NAFLD and the regulatory mechanisms of the TLR4/NF-κB cascade.</p><p><strong>Materials and methods: </strong>Male rats were fed an HFD to induce the NAFLD in vivo model. Changes in body weight and liver tissue weight were measured. Liver tissue damage and hepatic steatosis were monitored by hematoxylin-eosin staining in rats. Fat droplet size of rat liver tissue was detected by oil red O staining kit to evaluate fat deposition. Total cholesterol (TC), triglycerides (TG), alanine transaminase (ALT), Aspartate transaminase (AST), fatty acid synthase (FAS, and PPARα were detected by enzyme-linked immunosorbent assay (ELISA) kit and western blot. Interleukin-1-beta (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) were detected by ELISA. Finally, glucose tolerance and insulin sensitivity were measured by glucose analyzer.</p><p><strong>Results: </strong>IREB2 was highly expressed in the liver tissue of NAFLD rats. The body weight and liver tissue weight of rats with knockdown of IREB2 were lower than those fed HFD, and the liver tissue was severely damaged, serum ALT/AST activity, glucose, TG, and TC levels were increased. In addition, overexpressing IREB2 increased IL-1β, IL-6, and TNF-α, promoting HFD-induced metabolic disorders, hepatic steatosis, and inflammation. Knocking down IREB2 had the opposite effect. Blocking the TLR4/NF-κB cascade reversed the promoting effect of IREB2 on steatosis and inflammatory response.</p><p><strong>Conclusion: </strong>NAFLD treatment and prevention could benefit from IREB2, which may be closely related to TLR4/NF-κB signaling in lipid metabolism and glucose tolerance.</p>","PeriodicalId":51205,"journal":{"name":"Turkish Journal of Gastroenterology","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2025-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143257331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信